Minneapolis Heart Institute Foundation
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1982-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://mplsheart.org/
Corticosteroid Pulse After Ablation
Phase 4
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Drug: SolumedrolDrug: Placebo
- First Posted Date
- 2008-12-12
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Minneapolis Heart Institute Foundation
- Target Recruit Count
- 119
- Registration Number
- NCT00807586
- Locations
- ๐บ๐ธ
Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Deactivation of Implantable Cardioverter Defibrillator During Non-thoracic Surgical Procedures
Completed
- Conditions
- Implantable Cardioverter-Defibrillators
- First Posted Date
- 2008-12-10
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Minneapolis Heart Institute Foundation
- Target Recruit Count
- 100
- Registration Number
- NCT00806377
- Locations
- ๐บ๐ธ
Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Post-conditioning to Reduce Infarct Size
Not Applicable
Completed
- Conditions
- Myocardial Infarction
- Interventions
- Procedure: Post-conditioning
- First Posted Date
- 2008-09-19
- Last Posted Date
- 2013-12-05
- Lead Sponsor
- Minneapolis Heart Institute Foundation
- Target Recruit Count
- 43
- Registration Number
- NCT00755469
- Locations
- ๐บ๐ธ
Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
Phase 2
Terminated
- Conditions
- Aortic Valve Stenosis
- Interventions
- Device: External beam radiation therapyOther: Sham Control
- First Posted Date
- 2007-10-03
- Last Posted Date
- 2019-10-01
- Lead Sponsor
- Minneapolis Heart Institute Foundation
- Target Recruit Count
- 21
- Registration Number
- NCT00538759
- Locations
- ๐บ๐ธ
Lindner Clinical Trial Center, Cincinnati, Ohio, United States
๐บ๐ธAbbott Northwestern Hospital, Minneapolis, Minnesota, United States
Bone Marrow Stem Cell Infusion Following a Heart Attack
Phase 1
Completed
- Conditions
- Acute Myocardial Infarction
- Interventions
- Drug: Autologous, Unfractionated Bone Marrow Mononuclear Cells
- First Posted Date
- 2005-12-22
- Last Posted Date
- 2013-12-05
- Lead Sponsor
- Minneapolis Heart Institute Foundation
- Target Recruit Count
- 41
- Registration Number
- NCT00268307
- Locations
- ๐บ๐ธ
Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath